HBM HOLDINGS-B Independent Director Under Investigation by Chinese Securities Regulator

Stock News

May 13

HBM HOLDINGS-B (02142) announced that the company has been notified that its Independent Non-Executive Director, Dr. Ye Xiaoping, received an investigation notice from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notice pertains to alleged violations of information disclosure regulations related to shareholding changes in Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ; 3347.HK). In accordance with the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the CSRC has decided to initiate an investigation into Dr. Ye. Dr. Ye has stated he will fully cooperate with the CSRC's work and strictly fulfill information disclosure obligations as required by regulations. As an Independent Non-Executive Director, Dr. Ye is not involved in the day-to-day management or operations of the group. The company's board of directors believes the group's business operations remain normal and the aforementioned investigation will not affect the group's normal operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/news/1162773877"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162773877\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162773877?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 12:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162773877","market":"other","top_or_hot":-1,"title":"HBM HOLDINGS-B Independent Director Under Investigation by Chinese Securities Regulator","media":"Stock News","content":"<p>HBM HOLDINGS-B (02142) announced that the company has been notified that its Independent Non-Executive Director, Dr. Ye Xiaoping, received an investigation notice from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notice pertains to alleged violations of information disclosure regulations related to shareholding changes in Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ; 3347.HK). In accordance with the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the CSRC has decided to initiate an investigation into Dr. Ye. Dr. Ye has stated he will fully cooperate with the CSRC's work and strictly fulfill information disclosure obligations as required by regulations. As an Independent Non-Executive Director, Dr. Ye is not involved in the day-to-day management or operations of the group. The company's board of directors believes the group's business operations remain normal and the aforementioned investigation will not affect the group's normal operations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM HOLDINGS-B Independent Director Under Investigation by Chinese Securities Regulator</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM HOLDINGS-B Independent Director Under Investigation by Chinese Securities Regulator\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-13 12:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HBM HOLDINGS-B (02142) announced that the company has been notified that its Independent Non-Executive Director, Dr. Ye Xiaoping, received an investigation notice from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notice pertains to alleged violations of information disclosure regulations related to shareholding changes in Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ; 3347.HK). In accordance with the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the CSRC has decided to initiate an investigation into Dr. Ye. Dr. Ye has stated he will fully cooperate with the CSRC's work and strictly fulfill information disclosure obligations as required by regulations. As an Independent Non-Executive Director, Dr. Ye is not involved in the day-to-day management or operations of the group. The company's board of directors believes the group's business operations remain normal and the aforementioned investigation will not affect the group's normal operations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"","article_id":"1162773877","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162773877","pubTimestamp":1778646618,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HBM HOLDINGS-B (02142) announced that the company has been notified that its Independent Non-Executive Director, Dr. Ye Xiaoping, received an investigation notice from the China Securities Regulatory...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B","BK1574":"生物医药B类股","BK1583":"高瓴概念","BK1161":"生物科技"},"translate_title":"HBM HOLDINGS-B独立董事被中国证券监管机构调查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"HBM HOLDINGS-B (02142) announced that the company has been notified that its Independent Non-Executive Director, Dr. Ye Xiaoping, received an investigation notice from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notice pertains to alleged violations of information disclosure regulations related to shareholding changes in Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ; 3347.HK). In accordance with the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the CSRC has decided to initiate an investigation into Dr. Ye. Dr. Ye has stated he will fully cooperate with the CSRC's work and strictly fulfill information disclosure obligations as required by regulations. As an Independent Non-Executive Director, Dr. Ye is not involved in the day-to-day management or operations of the group. The company's board of directors believes the group's business operations remain normal and the aforementioned investigation will not affect the group's normal operations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}